Download DAFTAR PUSTAKA 1. Ferlay J, Shin HR, Bray F, Forman D, Mathers

DAFTAR PUSTAKA
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates
of worldwide burden of cancer in 2008: GLOBOCAN 2008. International
Journal of Cancer. 2010;127:2893-917.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman,D. Global
cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
3. Aziz, M.,F. Gynecological cancer in Indonesia. J Gynecol Oncol.
2009;20(1-8):8-10.
4. Nguyen L, Brewer CA, DiSaia PJ. Ovarian metastasis of stage IIB
squamous cell cancer of the cervix after radical parametrectomy and
oophoropexy. Gynecologic Oncology. 1998; 68:198–200.
5. Kurnia I, Et Al. Hubungan Antara Biomarker Proliferasi Sebelum dan
Setelah Radiasi 10 Gy dengan Respon Kemoradioterapi Kanker
Serviks. Seminar Nasional Keselamatan Kesehatan dan Lingkungan VI.
Jakarta, 15-16 Juni 2010.
6. Sharma R, Firdaus H , Maheshwari V, et al. Chemotherapy and
Management of Locally Advanced Carcinoma Cervix. Iranian Journal of
Pathology . 2012. 7 (4), 224 – 30
7. Kim J Y, Cho H Y, Lee KC, Hwang YJ, Lee M H et al. Tumor Apoptosis
In Cervical Cancer: Its Role As A Prognostic Factor In 42 Radiotherapy
Patients. Int. J. Cancer ( Radiat. Oncol . Invest) :96, 305-312 .2001
8. Hausen, H.Z., Papilloma Viruses and Cancer : From Basic Studies To
Clinical Application. Nature Publish Group. 2002. P.342-349.
73
9. Hietanen S, Lain S, Krausz E, Blattner C, Lane D P,. activation of p53
in cervical carcinoma cells by small molecules. Proc. Natl. Acad. Sci,
U.S.A. 97: 8501-8505. 2000.
10. Wong. R.S.Y. Apoptosis in Cancer : From Pathogenesis to Treatment.
Journal Of Experimental & Clinical Cancer Research.2011. p. 1-14
11. Ishikawa H, Mitsuhashi N, Sakurai H, Maebayashi K, Niibe H. The
Effect Of P53 Status And Human Papillomavirus Infection On The
Clinical Outcome Of Patients With Stage IIIB Cervical Carcinoma
Treated With Radiation Therapy Alone. Wiley Online Library. Volume
91. Issue 1. 2001. P 80-89
12. Syaifudin, M. 2007. Gen Penekan Tumor p53, Kanker dan Radiasi
Pengion (serial online), [cited 29th April 2016]. Available from: URL:
http://www.batan.go.id/ptkmr/Biomedika/Publikasi%202007/MS_BAlar
a_Vol_8_3_Apr07.pdf.
13. Kurnia I, Siregar B, Soetopo S, Ramli I, Kurjana T,et al. Correlation
Between Akt and p53 Expression and Chemoradiotheraphy Response
in Cervical Cancer Patients. Hayati Journal of Biosciences, Des 2014,
vol. 21, no.4, p. 173-179.
14. Hanprasertpong J, Tungsinmunkog K, Chichareon S, Wootipoom V,
Geater A, Et Al. Correlation Of p53 And Ki-67 (MIB- 1) Expression
With Clinicopathological Features and Prognosis of Early Stage
Cervical Squamous Cell Carcinoma, J. Obstet. Gynaecol. Res. Vol 36,
no. 3, p. 572-580, june 2010.
15. Bai, L. & Zhu, G. 2006. p53: Structure, Function and Therapeutic
74
Applications. (serial online), [cited 29th April 2016]. Available from :
URL: http://mupnet.com/ JOCM%202(4)%20141-153.pdf.
16. Kumar, V., Kabbas, A., Fausto, N. 2010. Robbins and Cotran
Pathologic Basis of Disease 8th ed. (serial online), [cited 29th April
2016].
Available
from:
URL:
http://www.microsoft.com/isapi/redir.dll?prd=ie&pver=6&ar=msnhome.
17. Ocviyanti D, Handoko Y. Peran Dokter Umum dalam Pencegahan
Kanker Serviks di Indonesia. J Indon Med Assoc, Januari 2013, Vol:
63(1).
18. Sukardja, I Dewa Gede., 2000. Onkologi Klinik. Surabaya : Airlangga
University Press.
19. Mardjikoen, prastowo., 2005. Tumor Ganas Alat Genitalia. Edisi
kedua. Jakarta: Yayasan Bina Pustaka Sarwono Prawirohardjo
20. Pecorelli S. FIGO Committee On Gynecologic Oncology. Revised FIGO
Staging for Carcinoma of The Vulva, Cervix, and Endometrium.
International Journal of Gynecology and Obstetrics 105 (2009) 103-104
21. Farid A, Gynecological cancer in Indonesia. J. Gynecol oncol .2009.
Maret:20(1):8-10.
22. Tjokronagoro, M. Biologi Sel Tumor Maligna. Fakultas Kedokteran
UGM, 2001.
23. American Cancer Society. The Science Behind radiation Therapy.
Available
at
URL
:
www.cancer.org/acs/groups/cid/documents/webcontent/003019-pdf.pdf
75
24. Dubben H.H, Thames H.D, Beck H, Tumor volume : a basic and
specific
response
predictor
in
radiotherapy,
Radiotherapy
and
Oncology, 47 (1998), p: 167-174.
25. Okaichi K, Izumi N, Takamura Y, Fukui S, Kudo T. Radiation Sensitivity
And Transcription Profiles In Various Mutant P53 Cells. Department of
radioisotope medicine, atomic bomb disease and hibakusha medicine
unit. Available at URL : cdn.intechopen.com/pdfs/32090.pdf
26. Bhardwaj S. Wani F A. Evaluating The Importance Of Apoptotic Index,
Mitotic Index And Turnover Index In Premalignant And Malignant Lesion
Of Cervix. Open Journal of Pathology, 2015, 5, 29-37.
27. Gupta K. Alam K, Maheshwari V, Khan R, Sharma R. Apoptotic index
and Mib-1 Antibody Expression In Premalignant And Malignant Lesion
Of Uterine Cervix. Gynecol Obstet. 2013,3:5
28. Hockel M. Sclenger K, Hockel S, Vaupel P. Hypoxic cervical cancers
with low apoptotic index are highly aggressive. Cancer research 59,
4525-4528. 1999
29. Ambari E et al. Kaspase-3 tidak dapat Digunakan sebagai Prediktor
Keberhasilan Pemberian Kemoterapi Neoajuvan Regimen PVB pada
Kanker Serviks Stadium IB-IIA. Indones J Obstet Gynecol Vol 37, No 3,
July 2013.
30. Wiebe E, Denny L, Thomas G. Cancer of the Cervix Uteri. FIGO Cancer
Reort 2012. International Journal of Gynecology & Obstetrics 119S2
(2012) S100–S109.
76
31. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS,
Rubinstein L, et al. New guidelines to evaluate the response to
treatment in solid tumor. J Natl Cancer Inst 2000; 92: 205 – 16.
32. Park OJ. 2003. Measuring Response in Solid Tumors: Comparison of
RECIST
and
WHO
Response
Criteria.
Jpn
J
Clin
Oncol
2003;33(10)533–537
33. Padhani AR, Ollivier L. The RECIST criteria: implications for diagnostic
radiologist. The British Journal of Radiology, 74(2001), 983–986
34. Cervical Cancer. Dalam Berek and Haecker, Gynecologic Oncology, 5th
edition. Lippincott Williams Publisher, 2010.
35. Maae E, Nielsen M, Steffensen KD, Jakobsen EH, Jakobsen A,
Sorensen FB. Estimation of immunohistochemical expression of VEGF
in ductal carcinomas of the breast. J Histochemist cytochemist.
2011;59:750-60.
36. National Cancer Institute. NCI dictionary of cancer terms. DIakses
tanggal
11
Januari
2017.
Terdapat
di:
http://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=653117
37. Ishibashi H, Suzuki T, Suzuki S, Moriya T, Kaneko C, Takizawa T,
Sunamori M, et al. Sex steroid hormone receptors in human thymoma. J
Clinic Endocrinol Metabolism. 2003;88(5):2309-17.
38. Rizzardi AE, Johnson AT, Vogel RI, Pambuccian SE, Henriksen J,
Skubitz APN, Metzger GJ, Schmechel SC. Quantitative comparison of
immunohistochemical staining measured by digital image analysis
versus pathologist visual scoring. Diagnos Pathol. 2012;7:1-10.
77
39. Qureshi A, Pervez S. Allred scoring for ER reporting and it’s impact in
clearly distinguishing ER negative from ER positive breast cancers. J
Pak Med Assoc. 2010;60:350-3.
40. Choudhury KR, Yagle KJ, Swanson PE, Krohn KA, Rajendran JG. A
robust
automated
measure
immunohistochemistry
of
images.
average
J
antibody
Histochemist
staining
in
Cytochemist.
2010;58:95-107.
41. Harvey JM, Remmele W, Goldhirsch A, Wolff AX. IVD certified breast
cancer panel. Immunohistology Breast Pathology. 2013. p1-2. Available
from
:
http://www.zytomed-systems.com/downloads/product-
flyer/immunohistology/262-ivd-certified-breast-cancer-panel/file.html.
[Accessed 11st January 2017]
42. Kaemmerer D, Peter L, Lupp A, Schulz S, Sanger J, Baum RP, Prasad
V, Hommann M. Comparing of IRS and Her2 as immunohistochemical
scoring schemes in gastroenteropancreatic neuroendocrine tumors. Int
J Clin Exp Pathol. 2012;5(3):187-94.
43. Fedchenko N, Reifenrath J. Different approaches for interpretation and
reporting of immunohistochemistry analysis results in the bone tissue –
a review. Fedchenko and Reifenrath Diagnostic Pathology. 2014;9:1-12.
44. Gasinska A, Urbanski K, Gruchala A, Biesaga B, Kojs Z. A Ratio Of
Apoptosis
To
Mitosis,
Proliferation
Pattern
And
Prediction
Of
Radiotherapy Response In Cervical Carcinoma. Laboratory of Radiation
Biology. Neoplasma. 49.6. 2002
78
45. Jain D, Srinivasan R, Patel F, Gupta S. Evaluation of p53 and Bcl-2
Expression Asprognostic Markers In Invasive Cervical Carcinoma Stage
IIB/III Patients Treated By Radiotherapy. Gynecologic Oncology 88, 2228. 2003
46. Singh A, Sharma H, Salhan S, Guppta S, Bhatla N et al. Evaluation Of
Expression Of Apoptosis-Related Proteins And Their Correlation With
HPV,
Telomerase
Activity,
Apoptoticindex
In
Cervical
Cancer.
Pathobiology. 2004;71:314-322.
47. Horn L, Fischer U, Hanel C, Kuhn H, Raptis G, Bilek B. p53 in Surgically
Treated And Pathologically Staged Cervical Cancer: Correlation With
Local Tumor Progression, But Not With Lymphatic Spread. Pathol. Res.
Pract . 197: 605-609 2011.
48. Carrilho C, Gouveia P, Cantel M, Matos A, Buane L, David L.
Characterization Of Human Papillomavirus Infection, p53 and Ki-67
Expression In Cervical Cancer Of Mozambican Women. Pathol. Res.
Pract. 199: 303-311. 2003
49. Vosmik M, Laco J, Sirak I, Beranek M, Hovorkova E et al. Prognostic
Significance Of Human Papillomavirus (HPV) Status And Expression Of
Selected
Markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and
Ki67/MIB-1) on Outcome After (Chemo-) Radiotherapy In Patients With
Squamous Cell Carcinoma Of Uterine Cervix. Springer. Path. Oncol.
Res.2013
79